Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.
Bensman, Timothy J
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis. [electronic resource] - Antimicrobial agents and chemotherapy 10 2017
Publication Type: Clinical Trial, Phase IV; Journal Article
1098-6596
10.1128/AAC.00988-17 doi
Adult
Aged
Anti-Bacterial Agents--pharmacokinetics
Azabicyclo Compounds--pharmacokinetics
Ceftazidime--pharmacokinetics
Cystic Fibrosis--pathology
Drug Combinations
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Monte Carlo Method
Prospective Studies
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Respiratory Tract Infections--drug therapy
Young Adult
beta-Lactamase Inhibitors--pharmacokinetics
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis. [electronic resource] - Antimicrobial agents and chemotherapy 10 2017
Publication Type: Clinical Trial, Phase IV; Journal Article
1098-6596
10.1128/AAC.00988-17 doi
Adult
Aged
Anti-Bacterial Agents--pharmacokinetics
Azabicyclo Compounds--pharmacokinetics
Ceftazidime--pharmacokinetics
Cystic Fibrosis--pathology
Drug Combinations
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Monte Carlo Method
Prospective Studies
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Respiratory Tract Infections--drug therapy
Young Adult
beta-Lactamase Inhibitors--pharmacokinetics